Exchange Rates 2010

Return to Exchange Rates

Table of Contents

1. December 2010
2. November 2010
3. October 2010
4. September 2010
5. August 2010
6. July 2010
7. June 2010
8. May 2010
9. April 2010
10. March 2010
11. February 2010
12. January 2010

December 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

November 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

October 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

September 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

August 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

July 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

June 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

May 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2009 will be used in the review of prices for existing medicines in the second half of 2009.

The international prices of an existing drug product for the period January to December 2009 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

April 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2009 will be used in the review of prices for existing medicines in the second half of 2009.

The international prices of an existing drug product for the period January to December 2009 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

March 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (and previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2009 will be used in the review of prices for existing medicines in the second half of 2009.

The international prices of an existing drug product for the period January to December 2009 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in April 2007, the exchange rates used are April 2007 since the following table includes four months before the date of the first sale of the drug product as per the Guidelines.

February 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2009 will be used in the review of prices for existing medicines in the second half of 2009.

The international prices of an existing drug product for the period January to December 2009 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

January 2010

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedule 3 of the Compendium of Guidelines, Policies and Procedures.

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2009 will be used in the review of prices for existing medicines in the second half of 2009.

The international prices of an existing drug product for the period January to December 2009 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.